fentaNYL citrate in 0 — Class I drug recall D-1152-2016
Terminated recall by Cantrell Drug Company, reported 2016-07-13, distributed nationwide. Subpotent Drug
| Recall number | D-1152-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2015-08-21 |
| Classified | 2016-07-06 |
| Reported by FDA | 2016-07-13 |
| Terminated | 2017-02-03 |
| Distributed | Nationwide (US) |
| Quantity | 884 syringes |
| Reason classes | potency |
| NDC | 52533-0024-45 |
| Lot numbers | 6234 |
| Expiration dates | 2015-09-20 |
Product
fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1152-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.